case study q&a: selecting initial treatment regimens for patients with advanced low-risk hl
Published 10 years ago • 204 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
3:31
case study q&a: defining the response of lymphoma treatment before high-dose chemotherapy
-
3:15
case study q&a: determining the optimum salvage therapy and salvage regimen
-
12:25
case study: 23-year-old female with classical hodgkin lymphoma with nodular sclerosis, stage lva
-
7:28
case study: challenges of hodgkin lymphoma in 1st relapse
-
16:23
dr loretta nastoupil: a case study on a male patient with follicular lymphoma and early progression
-
9:48
case study: relapsed mantle cell lymphoma
-
27:49
hodgkin disease: the past, the present, and the future
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
15:57
initial therapy of advanced stage hodgkin lymphoma: when to use abvd, a(bv)vd, and beacopp
-
22:34
what’s new in the initial management of hodgkin lymphoma?
-
2:21
how does pet/ct help in the selection of therapy for patients with hodgkin lymphoma?
-
18:55
how i manage advanced stage hodgkin lymphoma and what do i do at first relapse
-
1:00:02
update on hodgkin lymphoma | lrf webinars
-
6:30
ghsd hd18 study: reducing chemotherapy toxicity in advanced stage hodgkin lymphoma
-
49:16
23rd masterclass lecture on hodgkin's lymphoma - current treatment strategy, wednesday 31st may
-
33:05
debate: watch and wait in follicular lymphoma: should we treat immediately?
-
15:39
inhl patient case study
-
4:04
standards of care in hodgkin lymphoma
-
5:02
hd21: treatment-related morbidity in patients with hodgkin lymphoma treated with brecadd vs ebeacopp